Search results
Earnings call: TMC outlines strategic focus amid Q1 net loss By Investing.com
Investing.com· 18 hours agoThe Metals Company (TMC) presented a corporate and financial update in its Q1 2024 earnings call,...
How Oilers survived improbable Canucks rally to win Game 4
New York Times· 1 hour agoThe Vancouver Canucks almost came back, but the Edmonton Oilers came to play in Game 4. In a pivotal...
Earnings call: Southland reports revenue growth, faces mixed segment results
Investing.com· 1 day agoDespite the rise in revenue, the company faced a net loss of $400,000 for the quarter. The Civil...
Newmark Group First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Simply Wall St. via Yahoo Finance· 18 hours agoNet loss: US$16.3m (loss widened by 57% from 1Q 2023). US$0.093 loss per share (further deteriorated...
Exploring Three Growth Companies With High Insider Ownership On Euronext Amsterdam
Simply Wall St. via Yahoo Finance· 49 minutes agoAmidst a backdrop of fluctuating global markets, the Euronext Amsterdam stands out with its unique...
Earnings call: Hall of Fame Resort & Entertainment sees growth in Q1 By Investing.com
Investing.com· 11 hours agoDespite this growth, the company experienced a net loss of $14.9 million. The company is working on...
Weight Loss Maintained With Slow Taper of Semaglutide
Medscape· 1 day agoPersonalized doses and slow tapering of semaglutide (Wegovy or Ozempic, Novo Nordisk) in patients...
Earnings call: Radiant Logistics posts loss amid challenging market
Investing.com· 3 days agoRadiant Logistics, Inc. (NYSE: RLGT ) reported a net loss of $703,000 for the quarter ended March...
Wild's Marco Rossi scores a goal to remember as Austria erases a 5-goal deficit vs. Canada at worlds
New York Times· 6 hours agoThe hockey-playing population of Austria is about 1.3 percent of what you’ll find in Canada, and...
Earnings call: Ocugen reports progress in gene therapy trials and Q1 financials By Investing.com
Investing.com· 8 hours agoThe European Medicines Agency (EMA) also deemed the U.S.-based trial acceptable for a future market...